Search

Author/Creator Kowata, Shugo

2. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial. (26th August 2015)

Authors:
Oyake, Tatsuo; Kowata, Shugo; Murai, Kazunori; Ito, Shigeki; Akagi, Tomoaki; Kubo, Kohmei; Sawada, Kenichi; Ishida, Yoji
Journal:
European journal of haematology
Issue:
Volume 96:Number 6(2016:Jun.)
Page Start:
602
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study. (5th December 2022)

Authors:
Kuwana, Masataka; Ito, Tomoki; Kowata, Shugo; Hatta, Yoshihiro; Fujimaki, Katsumichi; Naito, Kensuke; Kurahashi, Shingo; Kagoo, Toshiya; Tanimoto, Kazuki; Saotome, So; Tomiyama, Yoshiaki
Other Names:
Koike Michiaki investigator.; Nakajima Yuki investigator.; Harada Hiroshi investigator.; Hangaishi Akira investigator.; Yokoyama Kenji investigator.; Cho Ryuko investigator.; Kyoda Katsunori investigator.; Kakinoki Yasutaka investigator.; Yoshida Masahiro investigator.; Shimizu Seiichi investigat...
Journal:
British journal of haematology
Issue:
Volume 200:Number 6(2023)
Page Start:
802
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Rapid reduction in BCR‐ABL1 transcript predicts deep molecular response in dasatinib‐treated chronic‐phase chronic myeloid leukaemia patients. (16th October 2017)

Authors:
Murai, Kazunori; Yamaguchi, Kohei; Ito, Shigeki; Miyagishima, Takuto; Shindo, Motohiro; Wakasa, Kentaro; Inomata, Mitsue; Nagashima, Takahiro; Kondo, Takeshi; Fujimoto, Nozomu; Yamamoto, Satoshi; Yonezumi, Masakatsu; Oyake, Tatsuo; Kowata, Shugo; Tsukushi, Yasuhiko; Mine, Takahiro; Meguro, Kuniak...
Journal:
European journal of haematology
Issue:
Volume 100:Number 1(2018)
Page Start:
27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial. Issue 3 (March 2020)

Authors:
Kimura, Shinya; Imagawa, Jun; Murai, Kazunori; Hino, Masayuki; Kitawaki, Toshio; Okada, Masaya; Tanaka, Hideo; Shindo, Motohiro; Kumagai, Takashi; Ikezoe, Takayuki; Uoshima, Nobuhiko; Sato, Tsutomu; Watanabe, Reiko; Kowata, Shugo; Hayakawa, Masaya; Hosoki, Takaaki; Ikeda, Kazuhiko; Kobayashi, Tsu...
Journal:
Lancet
Issue:
Volume 7:Issue 3(2020)
Page Start:
e218
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗